Interactions of hydrogen sulfide with myeloperoxidase

British Journal of Pharmacology

Volumn 172, Issue 6, 2015, Pages 1516-1532

  Pálinkás, Zoltán ^a   Furtmüller, Paul G ^b   Nagy, Attila ^a   Jakopitsch, Christa ^b   Pirker, Katharina F ^b   Magierowski, Marcin ^c   Jasnos, Katarzyna ^c   Wallace, John L ^c   Obinger, Christian ^b   Nagy, Péter ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF NATURAL RESOURCES AND LIFE SCIENCES   (Austria)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC ION; FERROUS ION; HYDROGEN SULFIDE; HYPOCHLOROUS ACID; MYELOPEROXIDASE; PEROXIDASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CATALYSIS; CIRCULAR DICHROISM; COLITIS; COLON; ELECTRON SPIN RESONANCE; ENDOTHELIUM; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IC50; IN VIVO STUDY; INFLAMMATION; MALE; NEUTROPHIL; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREDICTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RAT; REVIEW; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION; ANIMAL; METABOLISM; PHYSIOLOGY; WISTAR RAT;

ANIMALS; CIRCULAR DICHROISM; ELECTRON SPIN RESONANCE SPECTROSCOPY; HUMANS; HYDROGEN SULFIDE; INFLAMMATION; INHIBITORY CONCENTRATION 50; MALE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84923768701     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12769     Document Type: Review

References (75)

1. Aldib I, Soubhye J, Zouaoui Boudjeltia K, Vanhaeverbeek M, Rousseau A, Furtmüller PG, et al. (2012). Evaluation of new scaffolds of myeloperoxidase inhibitors by rational design combined with high-throughput virtual screening. J Med Chem 55: 7208-7218.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013). The Concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
3. Bir SC, Kevil CG, (2013). Sulfane sustains vascular health: insights into cystathionine gamma-lyase function. Circulation 127: 2472-2474.
4. Boyum A, (1968). Isolation of mononuclear cells and granulocytes from human blood-isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at L G. Scand J Clin Lab Invest Suppl 21: 77-89.
5. Bradley PP, Priebat DA, Christensen RD, Rothstein G, (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209.
6. Burner U, Jantschko W, Obinger C, (1999). Kinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and II. FEBS Lett 443: 290-296.
7. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, et al. (2009). Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 105: 365-374.
8. van Dalen CJ, Whitehouse MW, Winterbourn CC, Kettle AJ, (1997). Thiocyanate and chloride as competing substrates for myeloperoxidase. Biochem J 327 (Pt 2): 487-492.
9. Elrod JW, Calvert JW, Morrison J, Doeller JE, Kraus DW, Tao L, et al. (2007). Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function. Proc Natl Acad Sci USA 104: 15560-15565.
10. English DR, Hendrickson DN, Suslick KS, Eigenbrot CW, Scheidt WR, (1984). Low-spin five-coordinate ferric porphyrin complex: [5, 10, 15, 20-tetrakis (4-methoxyphenyl) porphyrinato] (hydrosulfido) iron (III). J Am Chem Soc 106: 7258-7259.
11. Flannigan KL, McCoy KD, Wallace JL, (2011). Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis. Am J Physiol 301: G188-G193.
12. Flannigan KL, Ferraz JGP, Wang R, Wallace JL, (2013). Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism. PLoS ONE 8: e71962.
13. Forbes LV, Furtmüller PG, Khalilova I, Turner R, Obinger C, Kettle AJ, (2012). Isoniazid as a substrate and inhibitor of myeloperoxidase: identification of amine adducts and the influence of superoxide dismutase on their formation. Biochem Pharmacol 84: 949-960.
14. Gong QH, Shi XR, Hong ZY, Pan LL, Liu XH, Zhu YZ, (2011). A new hope for neurodegeneration: possible role of hydrogen sulfide. J Alzheimers Dis 24 (Suppl. 2): 173-182.
15. Greiner R, Palinkas Z, Basell K, Becher D, Antelmann H, Nagy P, et al. (2013). Polysulfides link H2S to protein thiol oxidation. Antioxid Redox Signal 19: 1749-1765.
16. Halliwell B, Clement MV, Longa LH, (2000). Hydrogen peroxide in the human body. FEBS Lett 486: 10-13.
17. Hegde A, Bhatia M, (2011). Hydrogen sulfide in inflammation: friend or foe? Inflamm Allergy Drug Targets 10: 118-122.
18. Heinecke JW, (1997). Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis. Curr Opin Lipidol 8: 268-274.
19. Jantschko W, Furtmüller PG, Zederbauer M, Jakopitsch C, Obinger C, (2004). Kinetics of oxygen binding to ferrous myeloperoxidase. Arch Biochem Biophys 426: 91-97.
20. Johansson MW, Patarroyo M, Oberg F, Siegbahn A, Nilsson K, (1997). Myeloperoxidase mediates cell adhesion via the alpha M beta 2 integrin (Mac-1, CD11b/CD18). J Cell Sci 110 (Pt 9): 1133-1139.
21. Josephy PD, Eling T, Mason RP, (1982). The horseradish peroxidase-catalyzed oxidation of 3,5,3',5'-tetramethylbenzidine. Free radical and charge-transfer complex intermediates. J Biol Chem 257: 3669-3675.
22. Kettle AJ, Gedye CA, Winterbourn CC, (1997). Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem J 321: 503-508.
23. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
24. Kimura H, (2013). Physiological role of hydrogen sulfide and polysulfide in the central nervous system. Neurochem Int 63: 492-497.
25. Kimura H, (2014). Production and physiological effects of hydrogen sulfide. Antioxid Redox Signal 20: 783-793.
26. Kimura Y, Kimura H, (2004). Hydrogen sulfide protects neurons from oxidative stress. FASEB J 18: 1165-1167.
27. Kimura Y, Mikami Y, Osumi K, Tsugane M, Oka J, Kimura H, (2013). Polysulfides are possible H2S-derived signaling molecules in rat brain. FASEB J 27: 2451-2457.
28. King AL, Lefer DJ, (2011). Cytoprotective actions of hydrogen sulfide in ischaemia-reperfusion injury. Exp Physiol 96: 840-846.
29. Klebanoff SJ, (1968). Myeloperoxidase-halide-hydrogen peroxide antibacterial system. J Bacteriol 95: 2131-2138.
30. Klebanoff SJ, (2005). Myeloperoxidase: friend and foe. J Leukoc Biol 77: 598-625.
31. Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM, (2013). Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol 93: 185-198.
32. Koike S, Ogasawara Y, Shibuya N, Kimura H, Ishii K, (2013). Polysulfide exerts a protective effect against cytotoxicity caused by t-buthylhydroperoxide through Nrf2 signaling in neuroblastoma cells. FEBS Lett 587: 3548-3555.
33. Kraus DW, Wittenberg JB, Lu JF, Peisach J, (1990). Hemoglobins of the Lucina pectinata/bacteria symbiosis. II. An electron paramagnetic resonance and optical spectral study of the ferric proteins. J Biol Chem 265: 16054-16059.
34. Laggner H, Muellner MK, Schreier S, Sturm B, Hermann M, Exner M, et al. (2007). Hydrogen sulphide: a novel physiological inhibitor of LDL atherogenic modification by HOC1. Free Radical Res 41: 741-747.
35. Mani S, Li H, Untereiner A, Wu L, Yang G, Austin RC, et al. (2013). Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 127: 2523-2534.
36. Marquez LA, Dunford HB, (1997). Mechanism of the oxidation of 3,5,3',5'-tetramethylbenzidine by myeloperoxidase determined by transient- and steady-state kinetics. Biochemistry 36: 9349-9355.
37. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
38. Miljkovic JL, Kenkel I, Ivanovic-Burmazovic I, Filipovic MR, (2013). Generation of HNO and HSNO from nitrite by heme-iron-catalyzed metabolism with H2S. Angew Chem Int Ed 52: 12061-12064.
39. Nagy P, Winterbourn CC, (2010). Rapid reaction of hydrogen sulfide with the neutrophil oxidant hypochlorous acid to generate polysulfides. Chem Res Toxicol 23: 1541-1543.
40. Nagy P, Palinkas Z, Nagy A, Budai B, Toth I, Vasas A, (2014). Chemical aspects of hydrogen sulfide measurements in physiological samples. Biochim Biophys Acta 1840: 876-891.
41. Nakamura S, Nakamura M, Yamazaki I, Morrison M, (1984). Reactions of ferryl lactoperoxidase (compound-Ii) with sulfide and sulfhydryl compounds. J Biol Chem 259: 7080-7085.
42. Nashef AS, Osuga DT, Feeney RE, (1977). Determination of hydrogen sulfide with 5,5'-dithiobis-(2-nitrobenzoic acid), N-ethylmaleimide, and parachloromercuribenzoate. Anal Biochem 79: 394-405.
43. Nicholls P, (1961). The formation and properties of sulphmyoglobin and sulphcatalase. Biochem J 81: 374-383.
44. Nicholls P, Kim JK, (1981). Oxidation of sulphide by cytochrome aa3. Biochim Biophys Acta 637: 312-320.
45. Nicholls P, Kim JK, (1982). Sulphide as an inhibitor and electron donor for the cytochrome c oxidase system. Can J Biochem 60: 613-623.
46. Nicholls SJ, Hazen SL, (2005). Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25: 1102-1111.
47. Nussbaum C, Klinke A, Adam M, Baldus S, Sperandio M, (2013). Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid Redox Signal 18: 692-713.
48. Paul BD, Snyder SH, (2012). H2S signalling through protein sulfhydration and beyond. Nat Rev Mol Cell Biol 13: 499-507.
49. Pavlik JW, Noll BC, Oliver AG, Schulz CE, Scheidt WR, (2010). Hydrosulfide (HS-) coordination in iron porphyrinates. Inorg Chem 49: 1017-1026.
50. Peisach J, Blumberg WE, Ogawa S, Rachmilewitz EA, Oltzik R, (1971). The effects of protein conformation on the heme symmetry in high spin ferric heme proteins as studied by electron paramagnetic resonance. J Biol Chem 246: 3342-3355.
51. Pietri R, Lewis A, Leon RG, Casabona G, Kiger L, Yeh SR, et al. (2009). Factors controlling the reactivity of hydrogen sulfide with hemeproteins. Biochemistry 48: 4881-4894.
52. Pietri R, Roman-Morales E, Lopez-Garriga J, (2011). Hydrogen sulfide and hemeproteins: knowledge and mysteries. Antioxid Redox Signal 15: 393-404.
53. Rivers JR, Badiei A, Bhatia M, (2012). Hydrogen sulfide as a therapeutic target for inflammation. Expert Opin Ther Targets 16: 439-449.
54. Sen N, Paul BD, Gadalla MM, Mustafa AK, Sen T, Xu R, et al. (2012). Hydrogen sulfide-linked sulfhydration of NF-kappaB mediates its antiapoptotic actions. Mol Cell 45: 13-24.
55. Shen X, Peter EA, Bir S, Wang R, Kevil CG, (2012). Analytical measurement of discrete hydrogen sulfide pools in biological specimens. Free Radic Biol Med 52: 2276-2283.
56. Shibuya N, Tanaka M, Yoshida M, Ogasawara Y, Togawa T, Ishii K, et al. (2009). 3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain. Antioxid Redox Signal 11: 703-714.
57. Singh S, Banerjee R, (2011). PLP-dependent H2S biogenesis. Biochim Biophys Acta 1814: 1518-1527.
58. Soubhye J, Prevost M, Van Antwerpen P, Zouaoui Boudjeltia K, Rousseau A, Furtmüller PG, et al. (2010). Structure-based design, synthesis, and pharmacological evaluation of 3-(aminoalkyl)-5-fluoroindoles as myeloperoxidase inhibitors. J Med Chem 53: 8747-8759.
59. Soubhye J, Aldib I, Elfving B, Gelbcke M, Furtmüller PG, Podrecca M, et al. (2013). Design, synthesis, and structure-activity relationship studies of novel 3-alkylindole derivatives as selective and highly potent myeloperoxidase inhibitors. J Med Chem 56: 3943-3958.
60. Stamp LK, Khalilova I, Tarr JM, Senthilmohan R, Turner R, Haigh RC, et al. (2012). Myeloperoxidase and oxidative stress in rheumatoid arthritis. Rheumatology 51: 1796-1803.
61. Stipanuk MH, Beck PW, (1982). Characterization of the enzymic capacity for cysteine desulfhydration in liver and kidney of the rat. Biochem J 206: 267-277.
62. Stoll S, Schweiger AJ, (2006). EasySpin, a comprehensive software package for spectral simulation and analysis in EPR. J Magn Reson 178: 42-55.
63. Szabo C, (2007). Hydrogen sulphide and its therapeutic potential. Nat Rev Drug Discov 6: 917-935.
64. Tiden AK, Sjogren T, Svensson M, Bernlind A, Senthilmohan R, Auchere F, et al. (2011). 2-Thioxanthines are mechanism-based inactivators of myeloperoxidase that block oxidative stress during inflammation. J Biol Chem 286: 37578-37589.
65. Vitvitsky V, Kabil O, Banerjee R, (2012). High turnover rates for hydrogen sulfide allow for rapid regulation of its tissue concentrations. Antioxid Redox Signal 17: 22-31.
66. Wallace JL, Ferraz JG, Muscara MN, (2012). Hydrogen sulfide: an endogenous mediator of resolution of inflammation and injury. Antioxid Redox Signal 17: 58-67.
67. Wang JG, Mahmud SA, Nguyen J, Slungaard A, (2006). Thiocyanate-dependent induction of endothelial cell adhesion molecule expression by phagocyte peroxidases: a novel HOSCN-specific oxidant mechanism to amplify inflammation. J Immunol 177: 8714-8722.
68. Wang R, (2012). Physiological implications of hydrogen sulfide: a whiff exploration that blossomed. Physiol Rev 92: 791-896.
69. Wever R, Van Gelder BF, Dervartanian DV, (1975). Biochemical and biophysical studies on cytochrome c oxidase XX. Reaction with sulphide. Biochim Biophys Acta 387: 189-193.
70. Whiteman M, Winyard PG, (2011). Hydrogen sulfide and inflammation: the good, the bad, the ugly and the promising. Expert Rev Clin Pharmacol 4: 13-32.
71. Whiteman M, Haigh R, Tarr JM, Gooding KM, Shore AC, Winyard PG, (2010). Detection of hydrogen sulfide in plasma and knee-joint synovial fluid from rheumatoid arthritis patients: relation to clinical and laboratory measures of inflammation. Ann N Y Acad Sci 1203: 146-150.
72. Winterbourn CC, Kettle AJ, (2013). Redox reactions and microbial killing in the neutrophil phagosome. Antioxid Redox Signal 18: 642-660.
73. Yang G, Zhao K, Ju Y, Mani S, Cao Q, Puukila S, et al. (2013). Hydrogen sulfide protects against cellular senescence via S-sulfhydration of Keap1 and activation of Nrf2. Antioxid Redox Signal 18: 1906-1919.
74. Yap YW, Whiteman M, Cheung NS, (2007). Chlorinative stress: an under appreciated mediator of neurodegeneration? Cell Signal 19: 219-228.
75. Zanardo RC, Brancaleone V, Distrutti E, Fiorucci S, Cirino G, Wallace JL (2006). Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation. FASEB J 20: 21182120.